Melanotan 1 Peptide

For Research Use Only. Not for human use.

Melanotan 1 is a synthetic analog of α-MSH extensively used in pre-clinical research to investigate melanocortin-1 receptor (MC1R) signaling, eumelanin production pathways, tyrosinase activity, and UV-response modulation in melanocyte and skin models. This research-grade peptide is produced under stringent GMP-compliant conditions and provided as a lyophilized powder to ensure superior purity, stability, and reliability in experimental applications.

Engineered solely for preclinical investigations, each batch of Melanotan 1 receives a comprehensive quality assessment and includes complete documentation, such as a Certificate of Analysis (COA), purity data, and structural verification.

Scientific Overview

Melanotan 1 is a potent MC1R agonist with greater stability and affinity than native α-MSH in research settings. Preclinical investigations demonstrate Melanotan 1’s potential effects in the following areas:

• Stimulation of eumelanin synthesis and tyrosinase activity in melanocyte cultures
• Increase in melanin content in skin models, including those with MC1R variants
• Modulation of photoprotective responses and DNA repair pathways
• Influence on inflammatory signaling in dermal cell systems
• Support for studies on pigmentation dynamics without UV dependence

Why Researchers Choose Our Melanotan 1

For laboratories requiring dependable Melanotan 1 research peptide, our manufacturing process prioritizes reproducibility and scientific precision. Every batch is confirmed for:

• Purity and structural identity
• Consistent performance in laboratory research settings
• Rigorous production controls and full documentation
• Accessible pricing within the research community

Research-Referenced Functional Attributes (Based on existing preclinical and literature data—not intended as claims of therapeutic use)

• Activation of MC1R leading to elevated cAMP and upregulation of tyrosinase for eumelanin production in melanocyte models
• Significant increase in melanin density in human skin cell studies, even in MC1R variant genotypes
• Enhancement of tyrosinase activity up to 100-fold more potently than native α-MSH in melanoma cell lines
• Support for investigations into UV-independent pigmentation and photoprotective mechanisms
• Potential modulation of inflammatory signaling pathways in dermal cell models via MC1R agonism
• Examination of prolonged melanotropic effects in ex vivo and cell-based dermal systems